A carregar...

HIGH MOBILITY GROUP A: A NOVEL BIOMARKER AND THERAPEUTIC TARGET IN PANCREATIC ADENOCARCINOMA

High mobility group A1 proteins are architectural transcriptional factors that are over-expressed in a wide range of human malignancies. Recently published evidence suggests High mobility group A1 is a promising candidate biomarker and therapeutic target in pancreatic cancer. This review summarises...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Liau, S. S., Whang, E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3064443/
https://ncbi.nlm.nih.gov/pubmed/19848064
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!